TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46.3B | $44.6B | $42.9B | $42.9B | $44.9B | $39.2B | $32.2B | $25.5B | $24.4B | $20.9B | $18.3B | $17.0B | $16.9B | $13.1B | $12.5B | $11.6B | $10.4B | $9.9B | $10.5B | $9.7B |
| Cost of revenue | — | — | — | — | — | — | — | — | — | $9.0B | $8.2B | $7.6B | $7.9B | $6.3B | $6.1B | $5.7B | $5.3B | $5.2B | $5.3B | $5.1B |
| Gross profit | — | — | — | — | — | — | — | — | — | $11.9B | $10.1B | $9.4B | $9.0B | $6.8B | $6.4B | $5.8B | $5.1B | $4.8B | $5.2B | $4.7B |
| R&D | $1.4B | $1.4B | $1.4B | $1.3B | $1.5B | $1.4B | $1.2B | $1.0B | $967M | $887M | $754M | $692M | $691M | $396M | $376M | $340M | $284M | — | — | — |
| SG&A | $9.0B | $8.7B | $8.6B | $8.4B | $9.0B | $8.0B | $6.9B | $6.1B | $6.1B | $5.5B | $5.0B | $4.6B | $4.9B | $3.4B | $3.4B | $3.1B | $2.7B | $2.6B | $2.7B | $2.5B |
| Other operating expenses | — | — | — | — | — | — | — | — | — | $2.6B | $1.9B | $1.7B | $865M | $1.3B | $1.2B | $1.1B | $927M | $1.2B | $1.3B | $1.1B |
| Operating income | $8.1B | $7.7B | $7.3B | $6.9B | $8.4B | $10.0B | $7.8B | $4.6B | $3.8B | $3.0B | $2.5B | $2.3B | $2.5B | $1.6B | $1.5B | $1.3B | $1.2B | $1.0B | $1.2B | $974M |
| Non-operating income | −$509M | −$438M | −$300M | −$561M | −$558M | −$1.2B | −$569M | −$524M | −$521M | −$531M | −$434M | −$400M | −$416M | −$290M | −$213M | −$118M | −$100M | −$122M | — | — |
| Pretax income | $7.6B | $7.3B | $7.0B | $6.3B | $7.8B | $8.8B | $7.2B | $4.1B | $3.3B | $2.4B | $2.0B | $1.9B | $2.1B | $1.3B | $1.3B | $1.1B | $1.1B | $880M | — | — |
| Taxes | $670M | $604M | $702M | $303M | $885M | $1.1B | $850M | $374M | $324M | $204M | $2.0M | −$39M | $193M | $46M | $92M | −$197M | $52M | $30M | — | — |
| Net income | $7.0B | $6.7B | $6.3B | $6.0B | $7.0B | $7.7B | $6.4B | $3.7B | $2.9B | $2.2B | $2.0B | $2.0B | $1.9B | $1.3B | $1.2B | $1.3B | $1.0B | $850M | $981M | $748M |
| Diluted EPS | $18.59 | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | $5.59 | $5.09 | $4.92 | $4.71 | $3.48 | $3.21 | $3.46 | $2.53 | $2.01 | $2.25 | $1.69 |
| Diluted shares | — | 378.0M | 383.0M | 388.0M | 394.0M | 397.0M | 399.0M | 403.0M | 406.0M | 398.0M | 397.0M | 402.0M | 402.3M | 365.8M | 366.6M | 384.8M | 409.4M | 422.8M | 434.7M | 443.6M |
| Revenue growth | — | +3.9% | +0.1% | −4.6% | +14.5% | +21.7% | +26.1% | +4.9% | +16.4% | +14.5% | +7.7% | +0.4% | +29.0% | +4.6% | +8.2% | +11.2% | +4.9% | −5.6% | +7.7% | — |
| Gross margin | — | — | — | — | — | — | — | — | — | 57.1% | 55.1% | 55.3% | 53.0% | 51.8% | 51.2% | 50.4% | 49.3% | 48.0% | 49.5% | 47.9% |
| Operating margin | 17.6% | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | 14.2% | 13.5% | 13.8% | 14.8% | 12.3% | 11.8% | 10.8% | 11.4% | 10.1% | 11.7% | 10.0% |
| Net margin | 15.0% | 15.0% | 14.8% | 14.0% | 15.5% | 19.7% | 19.8% | 14.5% | 12.1% | 10.6% | 11.1% | 11.6% | 11.2% | 9.7% | 9.4% | 11.5% | 10.0% | 8.6% | 9.3% | 7.7% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.